Cargando…
Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD)(,,)()
BACKGROUND: The mechanisms underlying eye-related complications with dupilumab are poorly understood. OBJECTIVE: This study aimed to determine the incidence and characteristics of ocular complications with dupilumab and the prevalence of comorbid allergic contact dermatitis in the same subpopulation...
Autores principales: | Raffi, Jodie, Suresh, Raagini, Fishman, Harvey, Botto, Nina, Murase, Jenny E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938871/ https://www.ncbi.nlm.nih.gov/pubmed/31909149 http://dx.doi.org/10.1016/j.ijwd.2019.10.001 |
Ejemplares similares
-
Nonsteroid management of residual ocular surface disease on dupilumab (ROSDD),()()
por: Raffi, Jodie, et al.
Publicado: (2019) -
Allergic contact dermatitis masquerading as atopic dermatitis
por: Semaan, Sarah, et al.
Publicado: (2020) -
The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy
por: Suresh, Raagini, et al.
Publicado: (2018) -
Treatment of moist desquamation for patients undergoing radiotherapy()()
por: Suresh, Raagini, et al.
Publicado: (2019) -
Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab
por: Zhu, Gefei Alex, et al.
Publicado: (2019)